Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Forodesine | C11H14N4O4 | 209799-67-7 | Details |
| Promestriene | C22H32O2 | 39219-28-8 | Details |
| Fumonisin B2 | C34H59NO14 | 116355-84-1 | Details |
| Framycetin；Neomycin B;Fradiomycin B | C23H46N6O13 | 119-04-0 | Details |
| Fmoc-PEG4-Ala-Ala-Asn-PAB | C43H56N6O12 | 2055048-57-0 | Details |
| FW1256 | C12H10NOPS | 117089-08-4 | Details |
| Fmoc-PEG4-NHS ester | C30H36N2O10 | 1314378-14-7 | Details |
| Darifenacin hydrobromide | C28H31BrN2O2 | 133099-07-7 | Details |
| Foscarbidopa；Carbidopa 4′-monophosphate | C10H15N2O7P | 1907685-81-7 | Details |
| Fonadelpar；NPS-005;SJP-0035 | C25H23F3N2O4S | 515138-06-4 | Details |
| Fmoc-PEG6-NHS ester | C34H44N2O12 | 1818294-31-3 | Details |
| Fmoc-PEG5-NHS ester | C32H40N2O11 | 1402080-11-8 | Details |
| Fraxidin | C11H10O5 | 525-21-3 | Details |
| Foropafant | C28H40N4S | 136468-36-5 | Details |
| Ipatasertib dihydrochloride；RG-7440 dihydrochloride;GDC-0068 dihydrochloride | C24H33Cl2N5O2 | 1396257-94-5 | Details |
| Gboxin | C22H33ClN2O2 | 2101315-36-8 | Details |
| FX-11 | C22H22O4 | 213971-34-7 | Details |
| G-1 | C21H18BrNO3 | 881639-98-1 | Details |
| GANT 58 | C24H16N4S | 64048-12-0 | Details |
| GB1107 | C20H16Cl2F3N3O4S | 1978336-61-6 | Details |
| FR-190809 | C29H34FN3O6S2 | 215589-63-2 | Details |
| Fumonisin B1 | C34H59NO15 | 116355-83-0 | Details |
| GLPG0974 | C25H25ClN2O4S | 1391076-61-1 | Details |
| GLP-1R Antagonist 1 | C16H11ClF6N4O2 | 488097-06-9 | Details |
| Glibornuride | C18H26N2O4S | 26944-48-9 | Details |
| Glesatinib；MGCD265 | C31H27F2N5O3S2 | 936694-12-1 | Details |
| Glesatinib hydrochloride；MGCD265 hydrochloride | C31H28ClF2N5O3S2 | 1123838-51-6 | Details |
| Gidazepam；Gidasepam;Hydazepam;Hidazepam | C17H15BrN4O2 | 129186-29-4 | Details |
| GGsTop；Nahlsgen | C13H18NO7P | 926281-37-0 | Details |
| Gemcitabine elaidate；CO-101;Gemcitabine (elaidate);CP-4126;Gemcitabine 5'-elaidate | C27H43F2N3O5 | 210829-30-4 | Details |
| GR148672X | C15H11F3N2O2S | 263890-70-6 | Details |
| GMBS | C12H12N2O6 | 80307-12-6 | Details |
| GNE-049 | C27H32F2N6O2 | 1936421-41-8 | Details |
| GNE-0946 | C22H12ClF3N2O4 | 1677667-24-1 | Details |
| Glucagon (1-29), bovine, human, porcine hydrochloride | 28270-04-4 | Details |
| Glycerol phenylbutyrate | C33H38O6 | 611168-24-2 | Details |
| Drospirenone | C24H30O3 | 67392-87-4 | Details |
| GNE-781 | C27H33F2N7O2 | 1936422-33-1 | Details |
| GNF179 | C22H23ClFN5O | 1261114-01-5 | Details |
| GPNA hydrochloride | C11H14ClN3O5 | 67953-08-6 | Details |
| GR 159897 | C23H27FN2O2S | 158848-32-9 | Details |
| Griseoluteic acid | C15H12N2O4 | 489-76-9 | Details |
| GNE-207 | C29H30N6O3 | 2158266-58-9 | Details |
| Ravoxertinib hydrochloride；GDC-0994 (hydrochloride) | C21H19Cl2FN6O2 | 2070009-58-2 | Details |
| GDC-0339 | C20H22F3N7OS | 1428569-85-0 | Details |
| Gisadenafil | C23H33N7O5S | 334826-98-1 | Details |
| Glisoxepide | C20H27N5O5S | 25046-79-1 | Details |
| Glucagon (1-29), bovine, human, porcine；Porcine glucagon;Glucagon | C153H225N43O49S | 16941-32-5 | Details |
| Glufosinate | C5H12NO4P | 51276-47-2 | Details |
| Gly-PEG3-amine | C12H27N3O4 | 2110448-97-8 | Details |
| FN-1501 | C22H25N9O | 1429515-59-2 | Details |
| Sodium 4-phenylbutyrate | C10H13NaO2 | 1716-12-7 | Details |
| Fosdagrocorat；PF-04171327 | C29H30F3N2O5P | 1044535-58-1 | Details |
| Fosnetupitant；Pronetupitant | C31H35F6N4O5P | 1703748-89-3 | Details |
| Fosravuconazole；BMS-379224;E-1224 | C23H20F2N5O5PS | 351227-64-0 | Details |
| Fosteabine；Cytarabine ocfosfate;YNK 01 | C27H50N3O8P | 73532-83-9 | Details |
| Minocromil；FPL59360 | C18H16N2O6 | 85118-44-1 | Details |
| FR-188582 | C16H13ClN2O2S | 189699-82-9 | Details |
| gamma-DGG；γDGG;γ-D-Glutamylglycine | C7H12N2O5 | 6729-55-1 | Details |
| Galantide | C104H151N25O26S | 138579-66-5 | Details |
| Gabapentin enacarbil；XP-13512 | C16H27NO6 | 478296-72-9 | Details |
| Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB | C60H66N6O11 | 2055042-69-6 | Details |
| FR167344 free base | C30H28BrCl2N5O4 | 215258-13-2 | Details |
| FTY720 (S)-Phosphate；(S)-FTY720 phosphate;(S)-FTY720P | C19H34NO5P | 402616-26-6 | Details |
| FTI-2153 | C25H30N4O3S | 344900-92-1 | Details |
| FTBMT | C19H16F4N4O | 1358575-02-6 | Details |
| FT827 | C27H28N6O5S | 1959537-86-0 | Details |
| Furobufen | C16H12O4 | 38873-55-1 | Details |
| Funapide；XEN402;TV 45070 | C22H14F3NO5 | 1259933-16-8 | Details |
| Fructosyl-lysine；Fructoselysine | C12H24N2O7 | 21291-40-7 | Details |
| Valganciclovir hydrochloride | C14H23ClN6O5 | 175865-59-5 | Details |
| Fmoc-PEG3-C2-NHS ester | C28H32N2O9 | 1352827-47-4 | Details |
| G-744 | C29H29N5O3S | 1346669-54-2 | Details |
| Gardiquimod | C17H23N5O | 1020412-43-4 | Details |
| Rapamycin | C51H79NO13 | 53123-88-9 | Details |
| Gadoxetate Disodium | C23H28GdN3NaO11- | 135326-22-6 | Details |
| FzM1.8 | C18H14N2O4 | 2204290-85-5 | Details |
| Glyceryl monocaprate；Monocaprin;2,3-Dihydroxypropyl decanoate;DECANOIN | C13H26O4 | 26402-22-2 | Details |
| Inavolisib | C18H19F2N5O4 | 2060571-02-8 | Details |
| GI 181771 | C34H31N5O6 | 305366-98-7 | Details |
| Iloperidone | C24H27FN2O4 | 133454-47-4 | Details |
| Glufosfamide | C10H21Cl2N2O7P | 132682-98-5 | Details |
| GNE-4997 | C25H27F2N5O3S | 1705602-02-3 | Details |
| GNE-618 | C21H15F3N4O3S | 1362151-42-5 | Details |
| GNE-6468 | C23H16ClN3O4 | 1677668-27-7 | Details |
| GNE-955 | C22H24N8O | 1527523-39-2 | Details |
| GNE-0723；GNE 0723 | C16H8ClF6N5OS | 1883518-31-7 | Details |
| GNE 5729 | C17H10Cl2F3N5O | 2026635-66-3 | Details |
| GNF351 | C24H25N7 | 1227634-69-6 | Details |
| GPP78；CAY10618 | C27H29N5O | 1202580-59-3 | Details |
| GPR120 Agonist 3；GPR120-IN-1 | C19H23ClF3NO3 | 1599477-75-4 | Details |
| GR 113808 | C19H27N3O4S | 144625-51-4 | Details |
| GNE-272 | C22H25FN6O2 | 1936428-93-1 | Details |
| GNE-371 | C24H25N5O3 | 1926986-36-8 | Details |
| Doxepin hydrochloride | C19H22ClNO | 1229-29-4 | Details |
| GN44028 | C18H15N3O2 | 1421448-26-1 | Details |
| Glufosinate ammonium | C5H18N3O4P | 77182-82-2 | Details |
| GS-626510 | C25H22N4O | 1637770-13-8 | Details |
| GS-6201 | C21H21F3N6O2 | 752222-83-6 | Details |
| Fumitremorgin C | C22H25N3O3 | 118974-02-0 | Details |
| Product Total： Product Page： | ||||
| 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 | ||||